Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$2.9800
-0.0200 ( -1.06% ) 5.7K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$2.9800
Previous close
$3.0000
Volume
5.7K
Market cap
$202.76M
Day range
$3.0100 - $3.1750
52 week range
$2.2800 - $19.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Apr 08, 2024 |
8-k | 8K-related | 15 | Apr 03, 2024 |
8-k | 8K-related | 16 | Mar 28, 2024 |
10-k | Annual reports | 124 | Mar 28, 2024 |
8-k | 8K-related | 14 | Mar 25, 2024 |
8-k | 8K-related | 117 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
8-k | 8K-related | 103 | Mar 08, 2024 |
8-k | 8K-related | 22 | Mar 06, 2024 |
8-k | 8K-related | 104 | Feb 05, 2024 |